Clément DUPONT

Clément DUPONT

Lille, Hauts-de-France, France
1 k abonnés + de 500 relations

À propos

After a Master's degree in Biomedical engineering (Paul Sabatier University, Toulouse…

Activité

S’inscrire pour voir toute l’activité

Expérience

Publications

  • Photodynamic therapies of high-grade gliomas: from theory to clinical perspectives

    The main goal of this thesis is to provide technological tools to develop the photodynamic therapy for glioblastoma treatment.

    Voir la publication
  • A novel device for intraoperative photodynamic therapy dedicated to glioblastoma treatment

    Future Oncology

    Photodynamic therapy (PDT) appears to be a valuable new treatment modality for cancer therapy. Studies have reported successful application of PDT for glioblastoma. Here, we introduce a new device dedicated to intraoperative PDT delivered early after fluoro-guided resection combined with a transfer function that determines the treatment time based on the size of the surgical resection cavity.

    Voir la publication
  • Photodynamic therapy for glioblastoma: A preliminary approach for practical application of light propagation models

    Lasers in Surgery and Medicine

    Photodynamic therapy (PDT) is a promising treatment modality to be added in the management of glioblastoma multiforme (GBM). Light distribution modeling is required for planning and optimizing PDT. Several models have been developed to predict the light propagation inside biological tissues. In the present study, two analytical methods of light propagation emitted from a cylindrical fiber source were evaluated: a discrete and a continuous method.

    Voir la publication
  • 5-ALA Photodynamic Therapy in Neurosurgery, Towards the Design of a Treatment Planning System: A Proof of Concept

    IRBM

    Glioblastoma (GBM) treatment still remains a complex challenge. Among alternatives or adjuvant therapies, photodynamic therapy (5-ALA PDT) appears to be a promising approach. 5-ALA PDT can be delivered intraoperatively, early after tumour resection, or interstitially according to brain tumour location. A treatment planning system was designed to manage dosimetry issues before PDT delivery. The TPS was developed according to a specific workflow from stereotactic image registration to light…

    Glioblastoma (GBM) treatment still remains a complex challenge. Among alternatives or adjuvant therapies, photodynamic therapy (5-ALA PDT) appears to be a promising approach. 5-ALA PDT can be delivered intraoperatively, early after tumour resection, or interstitially according to brain tumour location. A treatment planning system was designed to manage dosimetry issues before PDT delivery. The TPS was developed according to a specific workflow from stereotactic image registration to light fluence rate modelling. Here, we describe a proof of concept of a treatment planning system (TPS) dedicated to interstitial 5-ALA PDT. This tool enables the planning of a whole treatment in surgical stereotactic conditions. Stereotactic registration and dosimetry components are detailed and evaluated. The registration process is compared to a commercial solution (Leksell Gamma Plan®, Elekta®, Sweden) defined as the ground truth and dosimetry model implemented in our TPS and is compared to numerical simulations. Registration achieved a sub-millimetric mean relative error that matched the standard MRI resolution. Dosimetry comparison showed a negligible error between analytical and numerical models and enabled a validation of the dosimetry algorithm implemented. A treatment planning system was designed to achieve 5-ALA PDT simulations before the patients underwent surgery. Similarly, for radiation therapy, we proposed a system to plan and evaluate the 5-ALA PDT dosimetry for optimizing treatment delivery. Although this system remains to be perfected, this preliminary work aimed to demonstrate the feasibility of planning 5-ALA PDT treatments in stereotactic conditions. Future improvements will mainly focus on the optimization of the treatment delivery, automatic segmentation and GPU-accelerated Monte-Carlo management to take into account GBM tissue heterogeneity.

    Voir la publication
  • On image segmentation methods applied to glioblastoma: State of art and new trends.

    IRBM

    Because of high heterogeneity and invasiveness, treatment of GlioBlastoma Multiform (GBM) still remains a complex challenge. Several recent advanced therapies have improved precision of treatment deliverance. Multimodality imaging plays an increasingly important role in this process and images segmentation has become an essential part of the pipeline of standard treatment planning system. With the sophistication of multimodality information, the development of reliable and robust segmentation…

    Because of high heterogeneity and invasiveness, treatment of GlioBlastoma Multiform (GBM) still remains a complex challenge. Several recent advanced therapies have improved precision of treatment deliverance. Multimodality imaging plays an increasingly important role in this process and images segmentation has become an essential part of the pipeline of standard treatment planning system. With the sophistication of multimodality information, the development of reliable and robust segmentation algorithms to overcome manual segmentation and optimize targeted treatment is highly expected.

    In this paper, we first introduce targeted therapies applied in the GBM clinical care, from routine or research. Different segmentation methods from state of the art are highlighted to achieve GBM delineation. New trends in GBM segmentation such as machine learning and multimodal features are discussed. These additional frameworks may achieve segmentation with refining capacities, active tumour probability mapping and, even, tumour relapse prediction capacities.

    Autres auteurs
    Voir la publication
  • Dosimetry dedicated to photodynamic therapy planning

    Physica Medica - 54èmes Journées Scientifiques SFPM

    Among new cancer therapies being developed, PhotoDynamic Therapy (PDT) appears as a realistic alternative to usual therapies. PDT is a selective and localized therapy consisting in lighting photosensitized tumor cells leading to a cytotoxic response. Here, we focus on the dosimetry part of treatment planning system and introduce a comparison between two light propagation modeling approaches.

    Autres auteurs
    Voir la publication
  • Photodynamic therapies of high-grade gliomas: from theory to clinical perspectives

    -

    The main goal of this thesis is to provide technological tools to develop the PDT for GBM treatment.

    Voir la publication

Projets

  • SYNAPS

    Synaps gathers scientific and clinical teams in Europe, to enhance the treatment of glioblastomas using laser-based photodynamic therapies.

    Photodynamic therapy (PDT) consists in exposing photosensitized tumour tissues to laser light, triggering the formation of molecules that kill malignant cells. This technology is potentially able to reach and selectively destroy tumour cells that cannot be removed through surgical resection. Beyond its efficacy, PDT is harmless for patient and thus…

    Synaps gathers scientific and clinical teams in Europe, to enhance the treatment of glioblastomas using laser-based photodynamic therapies.

    Photodynamic therapy (PDT) consists in exposing photosensitized tumour tissues to laser light, triggering the formation of molecules that kill malignant cells. This technology is potentially able to reach and selectively destroy tumour cells that cannot be removed through surgical resection. Beyond its efficacy, PDT is harmless for patient and thus deserves to be added in standard of care protocols.
    Despite demonstrating promising efficacy, PDT cannot be used today as a standard therapeutic modality because of the lack of reliable and reproducible therapy schemes, consensus on a photosentisizer and controlled multicentre clinical trial results.
    Synaps brings together specialized research and clinical teams across Europe, to tackle these challenges and develop a promising therapy.

    Autres créateurs
    Voir le projet

Prix et distinctions

  • 48-Hour Imagine Science Film Lab Competition

    Imagine Science Films - Pariscience

    The 48-Hour Imagine Science Film Lab Competition challenged gives teams comprised of scientists and filmmakers to create short films in just 48 hours. On opening night of Pariscience, a scientist and filmmaker met for the first time and were paired at random. The teams then have the next 48 hours to write, shoot, edit, and score their film. The winning film "Photodynamic Therapy" was celebrated for its ability to use a unique approach of vegetables and fruits to explain light-directed therapy…

    The 48-Hour Imagine Science Film Lab Competition challenged gives teams comprised of scientists and filmmakers to create short films in just 48 hours. On opening night of Pariscience, a scientist and filmmaker met for the first time and were paired at random. The teams then have the next 48 hours to write, shoot, edit, and score their film. The winning film "Photodynamic Therapy" was celebrated for its ability to use a unique approach of vegetables and fruits to explain light-directed therapy to remove malignant tumors.

    FR : https://vimeo.com/186097268
    EN : http://labocine.com/film/989

    http://www.sciencesetavenir.fr/sante/cerveau-et-psy/le-film-la-therapie-photodynamique-a-remporte-le-concours-un-film-en-48h-de-pariscience-2016_107474

Plus d’activités de Clément

Voir le profil complet de Clément

  • Découvrir vos relations en commun
  • Être mis en relation
  • Contacter Clément directement
Devenir membre pour voir le profil complet

Autres profils similaires

Autres personnes nommées Clément DUPONT (France)